Bullish
CervoMed prices $10M registered direct offering at $4/share
CervoMed Inc. has announced a registered direct offering to sell 2,500,000 shares of common stock at $4.00 per share, aiming to raise $10 million for ...
Bullish
CervoMed Inc. has announced a registered direct offering to sell 2,500,000 shares of common stock at $4.00 per share, aiming to raise $10 million for ...
Neutral
CervoMed (NASDAQ: CRVO) has announced a registered direct offering of 2.5 million common shares at $4.00 each, aiming to raise $10 million in gross pr...
Bullish
CervoMed Inc. announced a registered direct offering of 2,500,000 shares of common stock at $4.00 per share, totaling $10 million in gross proceeds. T...
CervoMed Inc. insiders who collectively purchased US$455.1k worth of stock at an average price of US$7.98 over the past year have seen their investmen...
Bearish
CervoMed insiders who bought shares at an average of US$7.98 are now facing losses as the stock has dropped by 17% to US$2.45, reducing their US$455.1...
CervoMed Inc. announced that its management will participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit. The company, which fo...
Bullish
CervoMed Inc (CRVO) has secured $10.5 million through a private placement to fund its Phase 3 clinical trials for Neflamapimod, a treatment for dement...
Bearish
CervoMed (CRVO) stock plummeted over 22% in pre-market trading after announcing a $10.5 million private placement financing, with potential for an add...